Yiling Pharmaceutical is a publicly traded Chinese pharma company (founded 1992, 5,001–10,000 employees) with a diversified portfolio spanning traditional Chinese medicine, Western pharmaceuticals, and biologics including CAR-T/NK cell production. The tech stack reveals active drug discovery and genomics work—Illumina, Oxford Nanopore, AlphaFold, GROMACS, PyMOL, TensorFlow—paired with research-grade bioinformatics databases (gnomAD, ClinVar). Hiring is heavily sales-focused (227 of 261 active roles), with decelerating velocity and widespread pain around low product awareness and market-share expansion, indicating a maturing organization shifting from growth-mode to conversion and channel optimization.
Tech Stack 19 technologies
What YILING PHARMACEUTICAL（以岭药业） Is Building
◆Challenges
- Low product awareness
- Expanding product market share
- Customer segmentation
- Meeting annual sales targets
- Channel flow maintenance
- Improving b2b competitiveness
- Improve brand awareness and conversion
- Enhance product competitiveness on jd
- Meeting marketing goals
- Expanding cmo/cdmo market presence
▲Active Projects
- Customer development plan
- Marketing strategy development
- Jd.com sales strategy development
- Market development plan
- Promote new product launch and old product sales
- Terminal promotion and theme promotion activities
- Car-t/nk cell production
- Sales plan implementation
- Regional market promotion plan
- Digital marketing budget management
Hiring Activity
Department
Seniority
Notable leadership hires: Agency Director
